
For Blood Cancer Awareness Month, Dr. Guenther Koehne shares why immunotherapy is making this a promising time for people with blood cancers.
Tumor testing can lead to different treatment choices and better outcomes.
Testing all cases of colon cancer for the presence of
Testing patients for biomarkers such as MSI status and Lynch syndrome can have treatment implications that ultimately lead to improved outcomes
Music: Bensound


